- Home
- PAVS vs ICCC Comparison
PAVS vs ICCC Comparison
Compare PAVS & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVS
- ICCC
- Stock Information
- Founded
- PAVS 2004
- ICCC 1982
- Country
- PAVS United States
- ICCC United States
- Employees
- PAVS N/A
- ICCC N/A
- Industry
- PAVS Medicinal Chemicals and Botanical Products
- ICCC Biotechnology: Pharmaceutical Preparations
- Sector
- PAVS Health Care
- ICCC Health Care
- Exchange
- PAVS Nasdaq
- ICCC Nasdaq
- Market Cap
- PAVS 63.1M
- ICCC 57.4M
- IPO Year
- PAVS 2019
- ICCC 1987
- Fundamental
- Price
- PAVS $1.02
- ICCC $6.56
- Analyst Decision
- PAVS
- ICCC
- Analyst Count
- PAVS 0
- ICCC 0
- Target Price
- PAVS N/A
- ICCC N/A
- AVG Volume (30 Days)
- PAVS 490.5K
- ICCC 15.6K
- Earning Date
- PAVS 08-04-2025
- ICCC 11-12-2025
- Dividend Yield
- PAVS N/A
- ICCC N/A
- EPS Growth
- PAVS N/A
- ICCC N/A
- EPS
- PAVS N/A
- ICCC 0.20
- Revenue
- PAVS $71,542.00
- ICCC $28,274,756.00
- Revenue This Year
- PAVS N/A
- ICCC N/A
- Revenue Next Year
- PAVS N/A
- ICCC N/A
- P/E Ratio
- PAVS N/A
- ICCC $31.65
- Revenue Growth
- PAVS N/A
- ICCC 21.75
- 52 Week Low
- PAVS $0.66
- ICCC $3.38
- 52 Week High
- PAVS $1.50
- ICCC $7.60
- Technical
- Relative Strength Index (RSI)
- PAVS 61.14
- ICCC 58.43
- Support Level
- PAVS $1.00
- ICCC $6.30
- Resistance Level
- PAVS $1.05
- ICCC $6.99
- Average True Range (ATR)
- PAVS 0.10
- ICCC 0.30
- MACD
- PAVS 0.01
- ICCC 0.06
- Stochastic Oscillator
- PAVS 69.39
- ICCC 69.06
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.